Tri-State TB Intensive Workshop

September 25 - 27, 2018

Faculty List
Continuing Education Information

Note: Presentations will be posted as they become available so please check back regularly for complete listing. Presentations may not be final versions and will be updated after the conference if needed.  

Day 1:
Diagnosis of TB Infection – Lisa Haglund, MD
Treatment of TB Infection – Thomas Herchline, MD
Approaches for Patient Education – Kimatha Hurst, RN
Strategies for Improving Treatment Completion – Gloria Smith, RN, CLC
B1, B2, B Ready – April Justice, RN

Day 2:
Epidemiology of TB – Karthik Kondapally, MPH & Premal Bhatt, MPH
Transmission & Pathogenesis of TB – Lisa Haglund, MD
Interpretation of Chest Radiographs – Sarah Tapyrik, MD
Laboratory Methods for Diagnosis of TB Disease – James Sunstrum, MD, Angie Schooley, & Rebecca Kramer
Treatment of Tuberculosis Disease – Sarah Tapyrik, MD
Managing Adverse Drug Reactions – Dana Kissner, MD

Day 3:
Extra-pulmonary Tuberculosis – James Sunstrum, MD
Management of Drug Resistant TB – Dana Kissner, MD
Role of TB Nurse Case Management – Gloria Smith, RN, CLC
TB and Alcohol Use Disorders – Trini Matthew, MD
TB and Diabetes – Charlie Bark, MD

Other Centers of Excellence (COE) – consult archived webinars on various TB topics, available products and resources

2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug Susceptible Tuberculosis

Other Guidelines

Reported Tuberculosis in the United States, 2016

WHO Global Tuberculosis Report 2018

All COE Products Page

Curry International TB Center
Drug-Resistant Tuberculosis: A Survival Guide for Clinicians, 3rd Edition

Radiographic Manifestations of Tuberculosis: A Primer for Clinicians, Second Edition

Funding for this conference was made possible (in part) by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.